Sales Desk – US  877.701.2883
Sales Desk – International  +353 1 525 9677
Money Pours Into Health-Care ETFs Spurred by New Drugs By Drew Armstrong For more information go to www.bloomberg.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future
Buffett upbeat about future despite trailing S&P By Josh Funk For more information go to http://www.washingtonpost.com/. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The
Berkshire Hathaway’s Profit Rises on Improving Economy By Anupreeta Das For more information go to www.online.wsj.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The
Nightly Business Report Hosted by Tyler Mathisen and Sue Herera For more information go to www.nrb.com. Â The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future
Buffett in Talks to Exit Stake in Former Washington Post Owner By Noah Buhayar and Zachary Trace For more information go to www.businessweek.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance
Pfizer’s Finally a Buy By Johanna Bennett For more information go to www.barrons.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and
Warren Buffett says, “What the wise man does in the beginning, the fool does in the end.” In a Barron’s feature over the weekend, writer Andrew Bary dug into the portfolio of Harvard’s Endowment through an interview with their CIO, Jane Mendillo. After all, who could possibly be wiser than what many would argue is the most respected undergraduate and graduate university in the world? Using a combination of Bary’s article and our perspective, this missive will seek to determine whether the Harvard Endowment is wise or foolish.
Why President Obama will keep doing well Cash Flow hosted by Oriel Morrison & Bernie Lo  The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future
Pfizer Aims at Lower Tax Rate as Share Buybacks Continue By Drew Armstrong For more information go to www.bloomberg.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of
In our business, we like to say that insider transactions never lie. For this reason, one of our eight criteria for selecting common stocks is strong insider ownership, preferably with recent purchases. Additionally, as contrarians, we want to make our original purchases in a business at a time when most investors are scared to buy for one reason or another. When we see officers, directors and substantial existing shareholders of a business buying at prices which are temporarily depressed, we raise our confidence in the long-term future of a business.
Which fund do you want to go to?
Smead Value FundSmead International Value Fund
take me back